首页 > 最新文献

Revista mexicana de urologia最新文献

英文 中文
Permixon® en el tratamiento de los síntomas del tracto urinario inferior por hiperplasia benigna de próstata: Nuevas aportaciones Permixon®在治疗良性前列腺增生下尿路症状中的新贡献
Q4 Medicine Pub Date : 2016-11-01 DOI: 10.1016/j.uromx.2016.10.003
A. Alcántara-Montero
{"title":"Permixon® en el tratamiento de los síntomas del tracto urinario inferior por hiperplasia benigna de próstata: Nuevas aportaciones","authors":"A. Alcántara-Montero","doi":"10.1016/j.uromx.2016.10.003","DOIUrl":"10.1016/j.uromx.2016.10.003","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 6","pages":"Page 398"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115816692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination therapy for the treatment of lower urinary tract symptoms in men 联合疗法治疗男性下尿路症状
Q4 Medicine Pub Date : 2016-11-01 DOI: 10.1016/j.uromx.2016.05.007
I. Barragán-Arteaga , L. Reyes-Vallejo

Recent interest in the coadministration of approved pharmaceutical agents has resulted in a wealth of emerging data on the safety and efficacy of dual pharmacological treatment for lower urinary tract symptoms (LUTS). Much evidence supports the coadministration of α-blockers with 5-alpha-reductase inhibitors (5-ARIs) in patients at risk for clinical progression. The use of phosphodiesterase-5 inhibitors (PDE5Is) in combination with 5-ARIs has also demonstrated a good safety and efficacy profile, providing early symptomatic relief and reduction of sexual side effects associated with 5-ARI use, although longer-term studies are needed. Studies investigating the combination of PDE5Is with α-blockers have shown additive effects on each of the individual agents with respect to the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF), which holds promise for patients who have shown a poor response to monotherapy. The coadministration of α-blockers and antimuscarinic agents provides an alternative for treatment of storage symptoms in patients who have failed to respond to monotherapy. This review aims to summarize and comment on available evidence regarding the safety and efficacy of combination treatment for LUTS.

最近对批准的药物药物联合用药的兴趣导致了大量关于双重药物治疗下尿路症状(LUTS)的安全性和有效性的新数据。许多证据支持α-受体阻滞剂与5- α-还原酶抑制剂(5-ARIs)在有临床进展风险的患者中联合使用。磷酸二酯酶-5抑制剂(PDE5Is)与5-ARI联合使用也显示出良好的安全性和有效性,提供早期症状缓解和减少与5-ARI使用相关的性副作用,尽管需要更长期的研究。研究PDE5Is与α-阻滞剂联合使用的研究显示,在国际前列腺症状评分(IPSS)和国际勃起功能指数(IIEF)方面,每种单独药物都有累加效应,这对那些对单一治疗反应不佳的患者来说是有希望的。α-受体阻滞剂和抗毒蕈碱药物的联合使用为治疗对单一疗法无效的患者的储存症状提供了另一种治疗方法。这篇综述旨在总结和评论关于联合治疗LUTS的安全性和有效性的现有证据。
{"title":"Combination therapy for the treatment of lower urinary tract symptoms in men","authors":"I. Barragán-Arteaga ,&nbsp;L. Reyes-Vallejo","doi":"10.1016/j.uromx.2016.05.007","DOIUrl":"10.1016/j.uromx.2016.05.007","url":null,"abstract":"<div><p>Recent interest in the coadministration of approved pharmaceutical agents has resulted in a wealth of emerging data on the safety and efficacy of dual pharmacological treatment for lower urinary tract symptoms (LUTS). Much evidence supports the coadministration of α-blockers with 5-alpha-reductase inhibitors (5-ARIs) in patients at risk for clinical progression. The use of phosphodiesterase-5 inhibitors (PDE5Is) in combination with 5-ARIs has also demonstrated a good safety and efficacy profile, providing early symptomatic relief and reduction of sexual side effects associated with 5-ARI use, although longer-term studies are needed. Studies investigating the combination of PDE5Is with α-blockers have shown additive effects on each of the individual agents with respect to the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF), which holds promise for patients who have shown a poor response to monotherapy. The coadministration of α-blockers and antimuscarinic agents provides an alternative for treatment of storage symptoms in patients who have failed to respond to monotherapy. This review aims to summarize and comment on available evidence regarding the safety and efficacy of combination treatment for LUTS.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 6","pages":"Pages 360-369"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.05.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124260850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Coriocarcinoma testicular con metástasis a coroides 睾丸绒毛膜癌伴脉络膜转移
Q4 Medicine Pub Date : 2016-11-01 DOI: 10.1016/j.uromx.2016.08.001
A. Cumming , J. Balanzario-Cuevas , J. Vitar-Sandoval , J. Monjaras-Guerra , J. Rodríguez-Robles , I. Cortés-Tapia , G. Regalado-Porras , E. Blancas , V.E. Corona-Montes

Introduction

Testicular tumors make up close to 1% of malignant tumors in men and 6% of the patients present with the disease between the ages of 20 and 35 years. Choriocarcinoma is a highly metastatic malignant tumor derived from undifferentiated trophoblasts. Ocular involvement in testicular tumors is extremely rare and occurs in 0.2% of cases.

Materials and methods

A 23-year-old man's disease symptoms began with intense headache associated with visual disturbances in the left eye and vertigo. He was referred to the Urology Department due to an enlarged left testis with a hardened consistency. Choriocarcinoma of the testis with metastases to the choroid, lung, and central nervous system was reported. After a cycle of chemotherapy, the patient presented with rapid deterioration of his vital functions and died in the intensive care unit. The pathology report stated metastatic testicular choriocarcinoma.

Discussion

Eighteen cases have been reported worldwide and the majority had very poor outcome. Prognosis in these cases was poor until the introduction of cisplatin-based chemotherapy in 1970. Choriocarcinoma is an aggressive variant of testicular carcinoma and has a high metastatic potential. Despite its hematogenous spread, it rarely metastasizes to the choroid.

Conclusions

Choriocarcinoma is an aggressive strain of testicular carcinoma with rapid hematogenous dissemination. Metastasis to the choroid is rare. Despite the combination of radiotherapy and chemotherapy, our patient's state of health deteriorated rapidly.

睾丸肿瘤占男性恶性肿瘤的近1%,年龄在20至35岁之间的患者占6%。绒毛膜癌是一种源自未分化滋养细胞的高度转移性恶性肿瘤。睾丸肿瘤累及眼部极为罕见,发生率仅为0.2%。材料与方法一名23岁男子的疾病症状开始于伴有左眼视力障碍和眩晕的剧烈头痛。他被转介到泌尿科,因为一个增大的左睾丸与硬化的一致性。据报道,睾丸绒毛膜癌转移到脉络膜,肺和中枢神经系统。经过一个周期的化疗后,患者的生命功能迅速恶化,死于重症监护病房。病理报告为转移性睾丸绒毛膜癌。全世界共报告了18例,其中大多数预后很差。这些病例的预后很差,直到1970年引入以顺铂为基础的化疗。绒毛膜癌是睾丸癌的一种侵袭性变异,具有很高的转移潜力。尽管它的血液传播,它很少转移到脉络膜。结论睾丸癌是一种血液传播迅速的侵袭性睾丸癌。转移到脉络膜是罕见的。尽管放疗和化疗相结合,我们的病人的健康状况迅速恶化。
{"title":"Coriocarcinoma testicular con metástasis a coroides","authors":"A. Cumming ,&nbsp;J. Balanzario-Cuevas ,&nbsp;J. Vitar-Sandoval ,&nbsp;J. Monjaras-Guerra ,&nbsp;J. Rodríguez-Robles ,&nbsp;I. Cortés-Tapia ,&nbsp;G. Regalado-Porras ,&nbsp;E. Blancas ,&nbsp;V.E. Corona-Montes","doi":"10.1016/j.uromx.2016.08.001","DOIUrl":"10.1016/j.uromx.2016.08.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Testicular tumors make up close to 1% of malignant tumors in men and 6% of the patients present with the disease between the ages of 20 and 35 years. Choriocarcinoma is a highly metastatic malignant tumor derived from undifferentiated trophoblasts. Ocular involvement in testicular tumors is extremely rare and occurs in 0.2% of cases.</p></div><div><h3>Materials and methods</h3><p>A 23-year-old man's disease symptoms began with intense headache associated with visual disturbances in the left eye and vertigo. He was referred to the Urology Department due to an enlarged left testis with a hardened consistency. Choriocarcinoma of the testis with metastases to the choroid, lung, and central nervous system was reported. After a cycle of chemotherapy, the patient presented with rapid deterioration of his vital functions and died in the intensive care unit. The pathology report stated metastatic testicular choriocarcinoma.</p></div><div><h3>Discussion</h3><p>Eighteen cases have been reported worldwide and the majority had very poor outcome. Prognosis in these cases was poor until the introduction of cisplatin-based chemotherapy in 1970. Choriocarcinoma is an aggressive variant of testicular carcinoma and has a high metastatic potential. Despite its hematogenous spread, it rarely metastasizes to the choroid.</p></div><div><h3>Conclusions</h3><p>Choriocarcinoma is an aggressive strain of testicular carcinoma with rapid hematogenous dissemination. Metastasis to the choroid is rare. Despite the combination of radiotherapy and chemotherapy, our patient's state of health deteriorated rapidly.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 6","pages":"Pages 387-391"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130985450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alfa-1 bloqueantes y resultados urodinámicos en varones con síntomas del tracto urinario inferior relacionados con obstrucción benigna de próstata: ¿fin de la controversia? α -1阻滞剂和与良性前列腺梗阻相关的下尿路症状男性的尿动力学结果:争议的结束?
Q4 Medicine Pub Date : 2016-11-01 DOI: 10.1016/j.uromx.2016.10.002
A. Alcántara-Montero
{"title":"Alfa-1 bloqueantes y resultados urodinámicos en varones con síntomas del tracto urinario inferior relacionados con obstrucción benigna de próstata: ¿fin de la controversia?","authors":"A. Alcántara-Montero","doi":"10.1016/j.uromx.2016.10.002","DOIUrl":"10.1016/j.uromx.2016.10.002","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 6","pages":"Pages 396-397"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122955106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México» [Rev Mex Urol. 2016;76:331] 《经皮肾石切开术结果及其与Guy和S.T.O.N.E.量表在墨西哥城一家医院的相关性》[Rev Mex Urol. 2016;76:331]
Q4 Medicine Pub Date : 2016-11-01 DOI: 10.1016/j.uromx.2016.11.001
J. Gómez-Sánchez, C. Martínez-Arroyo, M. Cantellano-Orozco, J.G. Morales-Montor, G. Fernández-Noyola, C. Pacheco-Gahbler, V. Cornejo-Dávila, J.A. Herrera-Muñoz, D.A. Preciado-Estrella
{"title":"Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México» [Rev Mex Urol. 2016;76:331]","authors":"J. Gómez-Sánchez,&nbsp;C. Martínez-Arroyo,&nbsp;M. Cantellano-Orozco,&nbsp;J.G. Morales-Montor,&nbsp;G. Fernández-Noyola,&nbsp;C. Pacheco-Gahbler,&nbsp;V. Cornejo-Dávila,&nbsp;J.A. Herrera-Muñoz,&nbsp;D.A. Preciado-Estrella","doi":"10.1016/j.uromx.2016.11.001","DOIUrl":"10.1016/j.uromx.2016.11.001","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 6","pages":"Page 399"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114053633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vigilancia en lesiones quísticas complejas y masas renales pequeñas: características radiológicas y evolución a mediano plazo 复杂囊性病变和小肾肿块的监测:放射学特征和中期演变
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.005
R. Ugalde-Resano , S. Vázquez-Manjarrez , J.D. Magaña-Rodríguez , C. Culebro-García , F. Gabilondo-Navarro , G. Feria-Bernal , F. Rodríguez-Covarrubias

Background

The detection of renal cell carcinoma has increased due to the wider availability of tomography. However, mortality figures have remained stable.

Aim

Our aim was to observe the progression of a group of patients with complex renal cysts or solid renal tumors that were closely monitored through imaging studies.

Material and methods

Nineteen kidney tumors were retrospectively included from patients that did not wish to undergo surgical treatment or whose comorbidities were contraindications for it. Each lesion was characterized and compared through initial and final CT-urography during follow-up.

Results

Sixty-eight percent of the lesions were catalogued as solid masses and 31% as complex cysts. Median surveillance was 33 months (range 6-88) and the mean growth rate was 0.2 cm/year. There was only one case of clinical stage progression.

Discussion

Strict surveillance of complex cystic and solid renal masses is a valid option in the initial management of some patients with small renal masses, mainly when comorbidities or age are contraindications for surgical treatment, due to their slow growth and low risk for progression. Nevertheless, more information at the national level is needed to have a higher level of evidence.

背景由于断层扫描技术的广泛应用,肾细胞癌的检出率有所提高。然而,死亡率数字保持稳定。目的我们的目的是观察一组通过影像学研究密切监测的复杂肾囊肿或实体肾肿瘤患者的进展情况。材料和方法回顾性纳入19例不希望接受手术治疗或合并症为禁忌症的患者的肾肿瘤。在随访期间,通过初始和最终的CT尿路造影对每个病变进行表征和比较。结果68%的病变被归类为实性肿块,31%的病变被分类为复杂囊肿。中位监测为33个月(范围6-88),平均生长率为0.2厘米/年。只有一例临床分期进展。讨论严格监测复杂的囊性和实体性肾脏肿块是一些小肾脏肿块患者的初步治疗的有效选择,主要是当合并症或年龄是手术治疗的禁忌症时,因为它们生长缓慢,进展风险低。然而,需要在国家一级提供更多信息,才能获得更高水平的证据。
{"title":"Vigilancia en lesiones quísticas complejas y masas renales pequeñas: características radiológicas y evolución a mediano plazo","authors":"R. Ugalde-Resano ,&nbsp;S. Vázquez-Manjarrez ,&nbsp;J.D. Magaña-Rodríguez ,&nbsp;C. Culebro-García ,&nbsp;F. Gabilondo-Navarro ,&nbsp;G. Feria-Bernal ,&nbsp;F. Rodríguez-Covarrubias","doi":"10.1016/j.uromx.2016.06.005","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.06.005","url":null,"abstract":"<div><h3>Background</h3><p>The detection of renal cell carcinoma has increased due to the wider availability of tomography. However, mortality figures have remained stable.</p></div><div><h3>Aim</h3><p>Our aim was to observe the progression of a group of patients with complex renal cysts or solid renal tumors that were closely monitored through imaging studies.</p></div><div><h3>Material and methods</h3><p>Nineteen kidney tumors were retrospectively included from patients that did not wish to undergo surgical treatment or whose comorbidities were contraindications for it. Each lesion was characterized and compared through initial and final CT-urography during follow-up.</p></div><div><h3>Results</h3><p>Sixty-eight percent of the lesions were catalogued as solid masses and 31% as complex cysts. Median surveillance was 33 months (range 6-88) and the mean growth rate was 0.2<!--> <!-->cm/year. There was only one case of clinical stage progression.</p></div><div><h3>Discussion</h3><p>Strict surveillance of complex cystic and solid renal masses is a valid option in the initial management of some patients with small renal masses, mainly when comorbidities or age are contraindications for surgical treatment, due to their slow growth and low risk for progression. Nevertheless, more information at the national level is needed to have a higher level of evidence.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 284-287"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recidiva local en cáncer de próstata por siembra durante prostatectomía radical retropúbica: a propósito de un caso 根治性前列腺后根治性切除术中种子前列腺癌局部复发:个案综述
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.008
O. González García, F. Jiménez Leiro, J.A. Valero Puerta, A.C. Valladares Ferreiro

A 67-year-old asymptomatic man had a slightly elevated prostate-specific antigen level 30 months after undergoing radical retropubic prostatectomy due to T1c adenocarcinoma of the prostate, with a Gleason score of 5. Physical examination only revealed a subcutaneous, infraumbilical, painless nodule of 3 cm coinciding with the incisional area of the abovementioned intervention. Computed axial tomography scan with contrast medium confirmed that finding, as well as the absence of suspicious adenopathies and other tumor foci. Local biopsy was performed, confirming the diagnosis of prostate cancer recurrence and the mass was completely excised.

Even when dealing with a tumor of slow growth and low Gleason score, the possibility of tumor cell seeding during surgery cannot be ignored. Therefore the basic principles of oncologic surgery must be strictly followed to optimally reduce this possibility.

一名67岁无症状男性,因T1c前列腺腺癌行根治性耻骨后前列腺切除术30个月后,前列腺特异性抗原水平略有升高,Gleason评分为5。体格检查仅发现一个3厘米的皮下、脐下无痛结节,与上述介入手术的切口区域一致。计算机轴位断层扫描与造影剂证实了这一发现,以及没有可疑的腺病变和其他肿瘤灶。行局部活检,确诊前列腺癌复发,肿块完全切除。即使对于生长缓慢、Gleason评分较低的肿瘤,术中肿瘤细胞播散的可能性也不容忽视。因此,必须严格遵循肿瘤手术的基本原则,以最大限度地减少这种可能性。
{"title":"Recidiva local en cáncer de próstata por siembra durante prostatectomía radical retropúbica: a propósito de un caso","authors":"O. González García,&nbsp;F. Jiménez Leiro,&nbsp;J.A. Valero Puerta,&nbsp;A.C. Valladares Ferreiro","doi":"10.1016/j.uromx.2016.06.008","DOIUrl":"10.1016/j.uromx.2016.06.008","url":null,"abstract":"<div><p>A 67-year-old asymptomatic man had a slightly elevated prostate-specific antigen level 30 months after undergoing radical retropubic prostatectomy due to T1c adenocarcinoma of the prostate, with a Gleason score of 5. Physical examination only revealed a subcutaneous, infraumbilical, painless nodule of 3<!--> <!-->cm coinciding with the incisional area of the abovementioned intervention. Computed axial tomography scan with contrast medium confirmed that finding, as well as the absence of suspicious adenopathies and other tumor foci. Local biopsy was performed, confirming the diagnosis of prostate cancer recurrence and the mass was completely excised.</p><p>Even when dealing with a tumor of slow growth and low Gleason score, the possibility of tumor cell seeding during surgery cannot be ignored. Therefore the basic principles of oncologic surgery must be strictly followed to optimally reduce this possibility.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 323-326"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115868329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baja morbilidad en niños operados de nefrectomía con técnica laparoscópica transperitoneal de 3 puertos 3孔经腹膜腹腔镜肾切除术儿童发病率低
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.006
M.A. Riquelme-Heras , R.A. Elizondo-Sáenz , G.E. Aguirre-Garza , J.J. Monterrubio-Rodríguez

Background

Even though laparoscopic nephrectomy is considered the gold standard in renal surgery in the adult, its role in the pediatric population is still a subject of debate. Laparoscopic nephrectomy has been shown to be a safe and effective procedure, compared with the open approach.

Aim

To present a case series of pediatric patients with different renal pathologies treated through transperitoneal laparoscopic nephrectomy.

Material and methods

Twenty-two pediatric patients that underwent transperitoneal laparoscopic nephrectomy were included in the study. All of the cases underwent the 3-port transperitoneal laparoscopic approach.

Results

All the kidneys were satisfactorily removed and the mean surgery duration was 142 min. There were no complications requiring conversion to open surgery in 21 of the 22 cases. Oral diet and ambulation were begun the same day of the surgery for all patients. Twenty of the 21 patients that did not require conversion were released on the second postoperative day.

Conclusions

We report herein on the transperitoneal laparoscopic approach for nephrectomy with the 3-port technique. It can be performed in the pediatric population with the same results and safety as other laparoscopic procedures and is an excellent alternative to traditional open surgery. This procedure should be considered for reducing surgical risk.

背景尽管腹腔镜肾切除术被认为是成人肾脏手术的黄金标准,但它在儿科人群中的作用仍然是一个有争议的话题。腹腔镜肾切除术已被证明是一个安全和有效的程序,与开放式相比。目的介绍一系列经腹膜腹腔镜肾切除术治疗不同肾脏疾病的儿童患者。材料和方法本研究纳入了22例接受腹膜内腹腔镜肾切除术的儿童患者。所有病例均采用3孔经腹膜腹腔镜入路。结果22例患者中,21例无需转为开放手术的并发症,平均手术时间142min。所有患者在手术当天开始口服饮食和活动。21名不需要转换的患者中有20名在术后第二天出院。结论本文报道了经腹膜腹腔镜三端口技术行肾切除术的方法。它可以在儿科人群中进行,与其他腹腔镜手术具有相同的效果和安全性,是传统开放手术的绝佳替代方案。为了降低手术风险,应考虑采用此程序。
{"title":"Baja morbilidad en niños operados de nefrectomía con técnica laparoscópica transperitoneal de 3 puertos","authors":"M.A. Riquelme-Heras ,&nbsp;R.A. Elizondo-Sáenz ,&nbsp;G.E. Aguirre-Garza ,&nbsp;J.J. Monterrubio-Rodríguez","doi":"10.1016/j.uromx.2016.06.006","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.06.006","url":null,"abstract":"<div><h3>Background</h3><p>Even though laparoscopic nephrectomy is considered the gold standard in renal surgery in the adult, its role in the pediatric population is still a subject of debate. Laparoscopic nephrectomy has been shown to be a safe and effective procedure, compared with the open approach.</p></div><div><h3>Aim</h3><p>To present a case series of pediatric patients with different renal pathologies treated through transperitoneal laparoscopic nephrectomy.</p></div><div><h3>Material and methods</h3><p>Twenty-two pediatric patients that underwent transperitoneal laparoscopic nephrectomy were included in the study. All of the cases underwent the 3-port transperitoneal laparoscopic approach.</p></div><div><h3>Results</h3><p>All the kidneys were satisfactorily removed and the mean surgery duration was 142 min. There were no complications requiring conversion to open surgery in 21 of the 22 cases. Oral diet and ambulation were begun the same day of the surgery for all patients. Twenty of the 21 patients that did not require conversion were released on the second postoperative day.</p></div><div><h3>Conclusions</h3><p>We report herein on the transperitoneal laparoscopic approach for nephrectomy with the 3-port technique. It can be performed in the pediatric population with the same results and safety as other laparoscopic procedures and is an excellent alternative to traditional open surgery. This procedure should be considered for reducing surgical risk.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 294-297"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Uretroplastia término-terminal para el tratamiento primario de la estenosis de uretra: experiencia del Hospital General Dr. Manuel Gea González 初级尿道狭窄的终末期尿道成形术:曼努埃尔·赫亚·冈萨雷斯综合医院的经验
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.001
L. Trujillo Ortiz, G. Garza-Sainz, E. Mayorga-Gómez, V. Osornio-Sánchez, V. Cornejo-Davila, I. Uberetagoyena-Tello, M.A. Palmeros-Rodríguez, J.E. Sedano-Basilio, J. Gómez-Sánchez, J.A. Herrera-Muñoz, D.A. Preciado-Estrella, M. Cantellano-Orozco, C. Martínez-Arroyo, G. Fernández-Noyola, J.G. Morales-Montor, C. Pacheco-Gahbler

Background

Urethral stricture is a urologic disease that has significant morbidity. Direct visual internal urethrotomy is used for the majority of cases in the United States, but end-to-end urethroplasty is the most successful technique. The choice of primary management is controversial. Direct visual internal urethrotomy is widely accepted in the majority of Mexican hospital centers. However, it is reported to have lower long-term success rates. Urethroplasty is indicated for long, densely fibrotic strictures. Diagnosis is based on radiologic studies (nuclear magnetic resonance or ultrasound, with contrast medium). Scales (Urethral Stricture Score) describing stricture complexity are employed to choose surgical treatment.

Aims

To communicate the results of primary treatment for urethral stricture in patients at the Hospital General Dr. Manuel Gea González that underwent end-to-end urethroplasty.

Materials and Methods

A descriptive study was conducted that reviewed the case records of 210 patients with urethral stricture, selecting the 58 cases that underwent end-to-end urethroplasty as primary treatment within the time frame of January 1, 2007 and December 31, 2013.

Results

The median age of the patients was 46.4 years. Stricture etiology: traumatic 23%, iatrogenic 58%, idiopathic 17%, and infectious 2%. The most frequent stricture location was at the bulbar level (87.9%) (51), mean length was 2.12 cm, 3 cases presented with double-site stricture, 11% (19) of the cases had urinary retention, and the mean urethral stricture score was 5.8. There were 10 recurrences, 9 re-interventions (urinary tract infection), and one augmented urethroplasty. Preoperative Qmax was 5.7-10 ml/sec and postoperative Qmax was 13-16 ml/sec. Cure was achieved in 82.7% of the cases.

Conclusions

Urethroplasty success rates worldwide are reported at 84-97%. Results are related to stricture complexity and surgical experience. There is still no consensus on success parameters. Urethroplasty presents less recurrence compared with direct visual internal urethrotomy, promoting long-term quality of life.

尿道狭窄是一种发病率较高的泌尿系统疾病。在美国,大多数病例使用直接视觉尿道内切开术,但端到端尿道成形术是最成功的技术。初级管理层的选择是有争议的。直接视觉尿道内切开术在大多数墨西哥医院中心被广泛接受。然而,据报道,它的长期成功率较低。尿道成形术适用于长而密集的纤维狭窄。诊断基于放射学研究(核磁共振或超声,使用造影剂)。使用描述狭窄复杂性的量表(尿道狭窄评分)来选择手术治疗。目的介绍在总医院接受端到端尿道成形术的Manuel Gea González医生治疗尿道狭窄的初步治疗结果。材料和方法回顾了210例尿道狭窄患者的病例记录,选择在2007年1月1日至2013年12月31日期间接受端到端尿道成形术作为主要治疗的58例患者。结果患者的中位年龄为46.4岁。狭窄病因:外伤性23%,医源性58%,特发性17%,感染性2%。最常见的狭窄部位在延髓水平(87.9%)(51),平均长度为2.12cm,3例出现双部位狭窄,11%(19)的病例出现尿潴留,平均尿道狭窄评分为5.8。有10例复发,9例再次干预(尿路感染),1例增强尿道成形术。术前Qmax为5.7-10毫升/秒,术后Qmax为13-16毫升/秒。治愈率为82.7%。结论全世界尿道成形术的成功率为84-97%。结果与狭窄的复杂性和手术经验有关。关于成功的参数仍然没有达成共识。与直接视觉尿道内切开术相比,尿道成形术的复发率较低,可提高长期生活质量。
{"title":"Uretroplastia término-terminal para el tratamiento primario de la estenosis de uretra: experiencia del Hospital General Dr. Manuel Gea González","authors":"L. Trujillo Ortiz,&nbsp;G. Garza-Sainz,&nbsp;E. Mayorga-Gómez,&nbsp;V. Osornio-Sánchez,&nbsp;V. Cornejo-Davila,&nbsp;I. Uberetagoyena-Tello,&nbsp;M.A. Palmeros-Rodríguez,&nbsp;J.E. Sedano-Basilio,&nbsp;J. Gómez-Sánchez,&nbsp;J.A. Herrera-Muñoz,&nbsp;D.A. Preciado-Estrella,&nbsp;M. Cantellano-Orozco,&nbsp;C. Martínez-Arroyo,&nbsp;G. Fernández-Noyola,&nbsp;J.G. Morales-Montor,&nbsp;C. Pacheco-Gahbler","doi":"10.1016/j.uromx.2016.06.001","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.06.001","url":null,"abstract":"<div><h3>Background</h3><p>Urethral stricture is a urologic disease that has significant morbidity. Direct visual internal urethrotomy is used for the majority of cases in the United States, but end-to-end urethroplasty is the most successful technique. The choice of primary management is controversial. Direct visual internal urethrotomy is widely accepted in the majority of Mexican hospital centers. However, it is reported to have lower long-term success rates. Urethroplasty is indicated for long, densely fibrotic strictures. Diagnosis is based on radiologic studies (nuclear magnetic resonance or ultrasound, with contrast medium). Scales (Urethral Stricture Score) describing stricture complexity are employed to choose surgical treatment.</p></div><div><h3>Aims</h3><p>To communicate the results of primary treatment for urethral stricture in patients at the Hospital General Dr. Manuel Gea González that underwent end-to-end urethroplasty.</p></div><div><h3>Materials and Methods</h3><p>A descriptive study was conducted that reviewed the case records of 210 patients with urethral stricture, selecting the 58 cases that underwent end-to-end urethroplasty as primary treatment within the time frame of January 1, 2007 and December 31, 2013.</p></div><div><h3>Results</h3><p>The median age of the patients was 46.4 years. Stricture etiology: traumatic 23%, iatrogenic 58%, idiopathic 17%, and infectious 2%. The most frequent stricture location was at the bulbar level (87.9%) (51), mean length was 2.12<!--> <!-->cm, 3 cases presented with double-site stricture, 11% (19) of the cases had urinary retention, and the mean urethral stricture score was 5.8. There were 10 recurrences, 9 re-interventions (urinary tract infection), and one augmented urethroplasty. Preoperative Qmax was 5.7-10<!--> <!-->ml/sec and postoperative Qmax was 13-16<!--> <!-->ml/sec. Cure was achieved in 82.7% of the cases.</p></div><div><h3>Conclusions</h3><p>Urethroplasty success rates worldwide are reported at 84-97%. Results are related to stricture complexity and surgical experience. There is still no consensus on success parameters. Urethroplasty presents less recurrence compared with direct visual internal urethrotomy, promoting long-term quality of life.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 275-278"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraganglioma vesical: causa rara de hematuria asintomática. Reporte de caso 膀胱副神经节瘤:无症状血尿的罕见原因。病例报告
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.05.003
J.L. Bizueto-Monroy , M.R. Fermín-Contreras , J. Ramírez-Velázquez , L.F. Parra-Izaguirre , A. San-Román-Vázquez

Paragangliomas of the urinary bladder are catecholamine-secreting tumors derived from chromaffin cells of the sympathetic nervous system. The most common symptoms are hematuria and paroxysmal hypertension. We describe herein a 67-year-old man that had bladder paraganglioma with hematuria and no associated symptomatology. The tumor was resected with no hemodynamic complications.

膀胱副神经节瘤是来源于交感神经系统嗜铬细胞的分泌儿茶酚胺的肿瘤。最常见的症状是血尿和阵发性高血压。我们在此描述一位67岁的男性,患有膀胱副神经节瘤伴血尿,无相关症状。肿瘤被切除,无血液动力学并发症。
{"title":"Paraganglioma vesical: causa rara de hematuria asintomática. Reporte de caso","authors":"J.L. Bizueto-Monroy ,&nbsp;M.R. Fermín-Contreras ,&nbsp;J. Ramírez-Velázquez ,&nbsp;L.F. Parra-Izaguirre ,&nbsp;A. San-Román-Vázquez","doi":"10.1016/j.uromx.2016.05.003","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.05.003","url":null,"abstract":"<div><p>Paragangliomas of the urinary bladder are catecholamine-secreting tumors derived from chromaffin cells of the sympathetic nervous system. The most common symptoms are hematuria and paroxysmal hypertension. We describe herein a 67-year-old man that had bladder paraganglioma with hematuria and no associated symptomatology. The tumor was resected with no hemodynamic complications.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 311-314"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Revista mexicana de urologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1